Recombinant erythropoietin are artificial forms of erythropoietin produced through recombinant DNA technology. They are commonly used to treat anemia associated with chronic kidney disease and chemotherapy. These drugs stimulate the bone marrow to produce more red blood cells, helping reduce the need for blood transfusions. The recombinant erythropoietins market has grown in importance owing to the development of new compounds which have a longer half-life and require less frequent dosing. ... Read more
